Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 12 |
GO:0016020 | membrane | 2 | 12 |
GO:0031090 | organelle membrane | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: A0A3Q8IJH0
Term | Name | Level | Count |
---|---|---|---|
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 5 | 12 |
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 4 | 12 |
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044255 | cellular lipid metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 12 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003975 | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016757 | glycosyltransferase activity | 3 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 119 | 123 | PF00656 | 0.414 |
CLV_MEL_PAP_1 | 181 | 187 | PF00089 | 0.523 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.366 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.379 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 155 | 159 | PF00082 | 0.245 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 297 | 301 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 311 | 315 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 320 | 324 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 370 | 374 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 454 | 458 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.336 |
DEG_APCC_DBOX_1 | 183 | 191 | PF00400 | 0.350 |
DEG_APCC_DBOX_1 | 296 | 304 | PF00400 | 0.198 |
DOC_CDC14_PxL_1 | 384 | 392 | PF14671 | 0.343 |
DOC_CYCLIN_RxL_1 | 43 | 50 | PF00134 | 0.551 |
DOC_MAPK_gen_1 | 151 | 158 | PF00069 | 0.445 |
DOC_MAPK_gen_1 | 194 | 200 | PF00069 | 0.198 |
DOC_MAPK_gen_1 | 337 | 347 | PF00069 | 0.505 |
DOC_PP1_RVXF_1 | 432 | 438 | PF00149 | 0.561 |
DOC_PP2B_PxIxI_1 | 326 | 332 | PF00149 | 0.334 |
DOC_PP4_FxxP_1 | 185 | 188 | PF00568 | 0.323 |
DOC_PP4_FxxP_1 | 375 | 378 | PF00568 | 0.314 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.326 |
DOC_USP7_MATH_1 | 279 | 283 | PF00917 | 0.383 |
DOC_USP7_MATH_1 | 299 | 303 | PF00917 | 0.114 |
DOC_USP7_MATH_1 | 360 | 364 | PF00917 | 0.445 |
DOC_USP7_UBL2_3 | 151 | 155 | PF12436 | 0.531 |
DOC_USP7_UBL2_3 | 68 | 72 | PF12436 | 0.598 |
DOC_USP7_UBL2_3 | 81 | 85 | PF12436 | 0.618 |
LIG_14-3-3_CanoR_1 | 212 | 216 | PF00244 | 0.350 |
LIG_14-3-3_CanoR_1 | 454 | 462 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 74 | 83 | PF00244 | 0.630 |
LIG_Actin_WH2_2 | 285 | 303 | PF00022 | 0.352 |
LIG_APCC_ABBA_1 | 424 | 429 | PF00400 | 0.579 |
LIG_BRCT_BRCA1_1 | 216 | 220 | PF00533 | 0.343 |
LIG_CtBP_PxDLS_1 | 89 | 93 | PF00389 | 0.474 |
LIG_eIF4E_1 | 368 | 374 | PF01652 | 0.336 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.413 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.301 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.307 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.356 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.251 |
LIG_FHA_1 | 256 | 262 | PF00498 | 0.313 |
LIG_FHA_1 | 369 | 375 | PF00498 | 0.245 |
LIG_FHA_1 | 406 | 412 | PF00498 | 0.592 |
LIG_FHA_1 | 434 | 440 | PF00498 | 0.457 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.561 |
LIG_GBD_Chelix_1 | 103 | 111 | PF00786 | 0.445 |
LIG_GBD_Chelix_1 | 422 | 430 | PF00786 | 0.307 |
LIG_HP1_1 | 124 | 128 | PF01393 | 0.142 |
LIG_IBAR_NPY_1 | 123 | 125 | PF08397 | 0.364 |
LIG_LIR_Gen_1 | 122 | 133 | PF02991 | 0.333 |
LIG_LIR_Gen_1 | 217 | 224 | PF02991 | 0.359 |
LIG_LIR_Gen_1 | 228 | 234 | PF02991 | 0.266 |
LIG_LIR_Gen_1 | 282 | 292 | PF02991 | 0.365 |
LIG_LIR_Gen_1 | 349 | 359 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 414 | 425 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 436 | 445 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 122 | 128 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 228 | 232 | PF02991 | 0.251 |
LIG_LIR_Nem_3 | 282 | 288 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 349 | 354 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 414 | 420 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 436 | 440 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 459 | 465 | PF02991 | 0.359 |
LIG_NRBOX | 136 | 142 | PF00104 | 0.328 |
LIG_NRBOX | 318 | 324 | PF00104 | 0.445 |
LIG_SH2_CRK | 417 | 421 | PF00017 | 0.472 |
LIG_SH2_PTP2 | 125 | 128 | PF00017 | 0.142 |
LIG_SH2_PTP2 | 229 | 232 | PF00017 | 0.337 |
LIG_SH2_SRC | 462 | 465 | PF00017 | 0.407 |
LIG_SH2_STAP1 | 351 | 355 | PF00017 | 0.298 |
LIG_SH2_STAP1 | 368 | 372 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.224 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.258 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.184 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.199 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.329 |
LIG_SH2_STAT5 | 351 | 354 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 417 | 420 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 425 | 428 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 455 | 458 | PF00017 | 0.300 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.266 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.302 |
LIG_SH3_3 | 210 | 216 | PF00018 | 0.323 |
LIG_SH3_3 | 391 | 397 | PF00018 | 0.405 |
LIG_SUMO_SIM_anti_2 | 102 | 108 | PF11976 | 0.349 |
LIG_SUMO_SIM_anti_2 | 134 | 139 | PF11976 | 0.301 |
LIG_SUMO_SIM_anti_2 | 173 | 178 | PF11976 | 0.383 |
LIG_SUMO_SIM_par_1 | 102 | 108 | PF11976 | 0.365 |
LIG_SUMO_SIM_par_1 | 24 | 30 | PF11976 | 0.412 |
LIG_SUMO_SIM_par_1 | 275 | 282 | PF11976 | 0.356 |
LIG_SUMO_SIM_par_1 | 357 | 363 | PF11976 | 0.383 |
LIG_UBA3_1 | 426 | 434 | PF00899 | 0.536 |
LIG_UBA3_1 | 53 | 60 | PF00899 | 0.591 |
LIG_WRC_WIRS_1 | 457 | 462 | PF05994 | 0.521 |
MOD_CK1_1 | 362 | 368 | PF00069 | 0.383 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.541 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.534 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.314 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.314 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.114 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.339 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.291 |
MOD_GSK3_1 | 362 | 369 | PF00069 | 0.333 |
MOD_GSK3_1 | 405 | 412 | PF00069 | 0.524 |
MOD_N-GLC_1 | 190 | 195 | PF02516 | 0.528 |
MOD_N-GLC_1 | 415 | 420 | PF02516 | 0.273 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.395 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.388 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.322 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.350 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.403 |
MOD_NEK2_1 | 354 | 359 | PF00069 | 0.291 |
MOD_NEK2_1 | 383 | 388 | PF00069 | 0.297 |
MOD_NEK2_1 | 411 | 416 | PF00069 | 0.476 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.401 |
MOD_NEK2_2 | 207 | 212 | PF00069 | 0.295 |
MOD_NEK2_2 | 34 | 39 | PF00069 | 0.346 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.350 |
MOD_PKB_1 | 398 | 406 | PF00069 | 0.564 |
MOD_Plk_1 | 415 | 421 | PF00069 | 0.481 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.411 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.362 |
MOD_Plk_4 | 248 | 254 | PF00069 | 0.377 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.345 |
MOD_Plk_4 | 272 | 278 | PF00069 | 0.314 |
MOD_Plk_4 | 279 | 285 | PF00069 | 0.314 |
MOD_Plk_4 | 349 | 355 | PF00069 | 0.312 |
MOD_Plk_4 | 368 | 374 | PF00069 | 0.275 |
MOD_Plk_4 | 415 | 421 | PF00069 | 0.470 |
MOD_Plk_4 | 456 | 462 | PF00069 | 0.424 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.418 |
MOD_SUMO_rev_2 | 429 | 436 | PF00179 | 0.565 |
TRG_DiLeu_BaLyEn_6 | 162 | 167 | PF01217 | 0.364 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.331 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 249 | 252 | PF00928 | 0.114 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 351 | 354 | PF00928 | 0.294 |
TRG_ENDOCYTIC_2 | 417 | 420 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 462 | 465 | PF00928 | 0.378 |
TRG_ER_diArg_1 | 397 | 400 | PF00400 | 0.508 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUV1 | Leptomonas seymouri | 71% | 100% |
A0A0S4IKK6 | Bodo saltans | 49% | 100% |
A0A1X0P351 | Trypanosomatidae | 46% | 100% |
A0A3R7MVB5 | Trypanosoma rangeli | 48% | 100% |
A4HPT7 | Leishmania braziliensis | 85% | 100% |
A4IE55 | Leishmania infantum | 100% | 100% |
D0A8Q1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ATK2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
P07286 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 100% |
P0CD61 | Dictyostelium discoideum | 36% | 100% |
P23338 | Cricetulus longicaudatus | 34% | 100% |
P24140 | Cricetulus griseus | 34% | 100% |
P42864 | Leishmania amazonensis | 93% | 100% |
P42867 | Mus musculus | 34% | 100% |
P42881 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 100% |
Q4Q0Z6 | Leishmania major | 96% | 100% |
Q5EA65 | Bos taurus | 34% | 100% |
Q9H3H5 | Homo sapiens | 35% | 100% |
V5B6U2 | Trypanosoma cruzi | 49% | 100% |